# Yutrepia

NDC: 72964-014
Generic name: treprostinil
Labeler / Manufacturer: Liquidia Technologies, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: RESPIRATORY (INHALATION)
Marketing started: 20250523

FDA application: NDA213005

## Active ingredients

- TREPROSTINIL SODIUM: 106 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72964-014"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72964-014
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e8f6d534-115c-440e-bdbb-b443a29bb468